GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 10
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Matthew Blackert, Fnp, FNP | Family | Canal Fulton, OH | $304.16 | $0 |
| Louisa Pittman, Aprn, APRN | Family | Sarasota, FL | $303.22 | $0 |
| Dr. Deborah Rosenfeld, D.p.m, D.P.M | Foot & Ankle Surgery | Marlton, NJ | $303.14 | $0 |
| James Dejesus, Dpm, DPM | Podiatrist | Naugatuck, CT | $301.70 | $0 |
| Razia Shareef, Pa-C, PA-C | Physician Assistant | Johns Creek, GA | $301.39 | $0 |
| Michael Jacobs | Physical Medicine & Rehabilitation | Bethesda, MD | $300.96 | $0 |
| Donald Erb, D.o, D.O | Interventional Pain Medicine | Sarasota, FL | $300.75 | $0 |
| Kenneth Reed, Md, MD | Pain Medicine | Tulsa, OK | $300.56 | $0 |
| Stephanie Clop, M.d, M.D | Physical Medicine & Rehabilitation | Aldie, VA | $299.95 | $0 |
| Jamie Otfinoski, Dpm, DPM | Foot Surgery | Bethel, CT | $299.61 | $0 |
| Dr. Clifton Jackness, Md, MD | Endocrinology, Diabetes & Metabolism | New York, NY | $298.68 | $0 |
| Oscar Coppes | Anesthesiology | Wauwatosa, WI | $298.45 | $0 |
| Magdalena Anitescu, Md, MD | Pain Medicine | Chicago, IL | $298.45 | $0 |
| Timothy Beacham, Md, MD | Pain Medicine | Louisville, KY | $298.29 | $0 |
| William Lichtenfeld, M.d, M.D | Pain Medicine | Johns Creek, GA | $297.73 | $0 |
| Dr. Bilal Dar, M.d, M.D | Pain Medicine | Houston, TX | $297.01 | $0 |
| Kay Hood, Agacnp-Bc, AGACNP-BC | Acute Care | St Augustine, FL | $293.86 | $0 |
| Douglas Bez, Do, DO | Anesthesiology | Lansing, MI | $292.96 | $0 |
| Mrs. Deana Smart, P.a, P.A | Physician Assistant | Winston Salem, NC | $292.68 | $0 |
| Henry Lepore, Md, MD | Physical Medicine & Rehabilitation | Sunset Beach, NC | $291.74 | $0 |
| Ashley Perry, Cfnp, CFNP | Family | Long Beach, MS | $291.60 | $0 |
| Dr. Jennifer Wu, M.d, M.D | Obstetrics & Gynecology | New York, NY | $291.60 | $0 |
| Dr. Francisco Ward, Do, DO | Interventional Pain Medicine | Columbia, MD | $290.22 | $0 |
| Mr. Steven Brewer, Pa, PA | Physician Assistant | Richmond, VA | $289.16 | $0 |
| Marie Hanna, M.d, M.D | Anesthesiology | Baltimore, MD | $288.67 | $0 |
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.